Skip to content

How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?

How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02505958
Enrollment
1
Registered
2015-07-22
Start date
2014-08-31
Completion date
2023-12-31
Last updated
2022-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

insulin resistance, obesity, caloric intake

Brief summary

Objective: To show that a 1-2 day reduction of caloric intake can reduce the insulin resistance produced by several days of overnutrition. Approach: Healthy volunteers will be admitted to the Clinical Research Center and undergo a baseline euglycemic-hyperinsulinemic clamp study to assess their insulin resistance. Subjects will then start on an overnutrition program for 4 days consisting of 3 meals and 3 snacks containing \ 6,000 Kcal/24hours. A second clamp study will be performed on day 5 to demonstrate the overnutrition induced increase in insulin resistance. Starting on day 5 the subject's caloric intake will be reduced to \ 1,000 Kcal for 2 days (day 5 and 6). After that on the morning of day 7, a third hyperinsulinemic-euglycemic clamp will be performed to determine whether the reduced caloric intake did reduce insulin resistance and the volunteer will be discharged from the Clinical Research Center.

Detailed description

Study volunteers will be admitted to the Clinical Research Center at Temple University Hospital. After an overnight fast, body composition will be determined non-invasively by bioimpedance analysis (4) and a 4 h euglycemic-hyperinsulinemic clamp (using only FDA-approved regular insulin) as previously described (5) will be performed during which serum samples will be obtained for measurement of glucose, insulin, free fatty acids, ketone bodies and lipids. Oxidative stress ( 6) will be measured by 24 hour urine collections (analyzed for isoprostane content via 8-isoprostaglandin-F2alpha throughout the study period. Respiratory gas exchange rates (7) will be determined at hourly intervals (with a metabolic cart (True One, Parvo Utah) during the clamp studies and once a day on Days 2 through 6. After that, (at about 1:00 in the afternoon on Day 1) the volunteers will be started on a diet program for 4 ½ days, consisting of 3 meals and 3 snacks over a 24 hour period and containing \ 6000 Kcal/24 h. The main meals (containing \ 1500 Kcal/meal) will be served at \ 8:00 in the morning (breakfast), 1:00 in the afternoon (lunch) and approximately 7:00 in the evening (dinner), the snacks (\ 500 Kcal/each) at approximately 11:00 in the morning, 4:00 in the afternoon and 11:00 in the night. On days 5 and 6, volunteers will receive 3 meals, each will contain \ 333 calories. Each morning blood samples will be obtained to measure glucose insulin, free fatty acids and ketone bodies. Daily 24 h urine collections will be obtained each day. In the morning of Days 5 and 7, all procedures described for Day 1 will be repeated. In the afternoon of Day 7, the volunteers will be discharged from the hospital.

Interventions

OTHERhigh caloric intake

Volunteers will be started on a diet program for 4 ½ days, consisting of 3 meals and 3 snacks over a 24 hour period and containing \ 6000 Kcal/24 h.

OTHERreduced caloric intake

On days 5 and 6, volunteers will received 3 meals (\ 333 calories each) totaling \ 1,000 calories/24 hours.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Temple University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy non-obese men and women -

Exclusion criteria

Subjects with diabetes or a history of obesity surgery or with more than modest health problems \-

Design outcomes

Primary

MeasureTime frameDescription
Changes in body compositionbaseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7Body composition will be determined by bioelectric impedance analysis
Changes in insulin resistancebaseline, day 4 and day 7Insulin resistance will be determined by measuring changes in insulin-stimulated total body glucose uptake during euglycemic hyperinsulinemic clamping
Changes in oxidative stressbaseline, day1, day 2, day 3, day 4, day 5, day 6, day 724 hour urine collections analyzed for isoprostane content
Changes in energy expenditurebaseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7Changes in energy expenditure will be assessed with a metabolic cart (indirect calorimetry)
Changes in weightbaseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7Subjects will be weighed daily

Secondary

MeasureTime frameDescription
Changes in blood glucose levelsbaseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7Daily blood samples will be analyzed to determine glucose levels of glucose.
Changes in blood levels of insulinBaseline, day1 day2, day 3, day 4, day 5, day 6, day 7Daily blood samples will be analyzed to determine insulin levels
Changes in blood levels of free fatty acidsBaseline, day1 , day 2, day 3, day 4, day 5, day 6, day 7Daily blood samples will be analyzed to determine free fatty acid levels
Changes in blood ketone levelsbaseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7Daily blood samples will be analyzed to determine ketone levels
Changes in glucagon levelsbaseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7Daily blood samples will be analyzed to determine glucagon levels

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026